Hydrogel-driven construction of integrated cancer theranostic platforms: from diagnosis to therapy

Abstract

Current cancer treatment still relies largely on stage-specific diagnosis and relatively fixed therapeutic regimens, while diagnostic information, therapeutic intervention, and efficacy feedback are often separated across different time windows. This fragmentation limits the ability to meet the demands of precision and individualized therapy. Theranostic platforms integrate disease diagnosis with therapeutic decision-making and can provide concurrent feedback on, or prediction of, treatment efficacy, enabling continuous assessment throughout the therapeutic course. Hydrogels are soft materials with tissue-like three-dimensional networks whose biofunctional properties permit stable loading of imaging probes and therapeutic agents, as well as controlled release and treatment monitoring at lesion sites. These features make hydrogels promising material platforms for integrated cancer theranostics. This review systematically summarizes hydrogel construction strategies for different diagnostic and therapeutic scenarios, emphasizing how matrix composition, crosslinking mode, and emerging materials influence platform performance. We further examined advances in hydrogel research for precision oncology over the past three years, with particular attention to emerging applications in cancer diagnosis and treatment. Building on this overview, we summarized the key oncological applications of hydrogel-based theranostic platforms according to distinct feedback modes. We also assessed the major limitations that currently hinder their development and discussed potential strategies to address them. Finally, we examined the challenges that continue to hinder real-world implementation and considered how integration with emerging technologies may shape the future of the field. Overall, this review provides a systematic framework for designing next-generation hydrogel-based cancer theranostic platforms that combine personalization, continuous monitoring, and realistic potential for clinical translation.

Keywords

Hydrogels / cancer / diagnosis / therapy / theranostic platforms

References

[1] GBD 2023 Cancer Collaborators. The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.Lancet2025;406:1565-86 PMCID:PMC12687902

[2] Schwartzberg L,Liu D.Precision oncology: who, how, what, when, and when not?.Am Soc Clin Oncol Educ Book2017;37:160-9

[3] El-Deiry WS,Lenz HJ.The current state of molecular testing in the treatment of patients with solid tumors, 2019.CA Cancer J Clin2019;69:305-43 PMCID:PMC6767457

[4] Kelkar SS.Theranostics: combining imaging and therapy.Bioconjug Chem2011;22:1879-903

[5] Xie Y.A caged drug enables precision delivery.Science2025;388:1371-2

[6] Gerlinger M,Horswell S.Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.N Engl J Med2012;366:883-92 PMCID:PMC4878653

[7] Marusyk A,Polyak K.Intratumor heterogeneity: the rosetta stone of therapy resistance.Cancer Cell2020;37:471-84 PMCID:PMC7181408

[8] Bardelli A.Liquid biopsies, what we do not know (yet).Cancer Cell2017;31:172-9

[9] Collins FS.A new initiative on precision medicine.N Engl J Med2015;372:793-5 PMCID:PMC5101938

[10] Choi KY,Lee S.Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.Nanoscale2012;4:330-42 PMCID:PMC3629960

[11] Rowe SP.Molecular imaging in oncology: current impact and future directions.CA Cancer J Clin2022;72:333-52 PMCID:PMC9189244

[12] O’Connor JPB,Adams JE.Imaging biomarker roadmap for cancer studies.Nat Rev Clin Oncol2017;14:169-86 PMCID:PMC5378302

[13] Mehta P,Devi M.Hydrogels: an overview of its classifications, properties, and applications.J Mech Behav Biomed Mater2023;147:106145

[14] Li J.Designing hydrogels for controlled drug delivery.Nat Rev Mater2016;1:16071 PMCID:PMC5898614

[15] Sun Z,Wang C,Wu J.Hydrogel-based controlled drug delivery for cancer treatment: a review.Mol Pharm2020;17:373-91

[16] Solanki R.Stimulus-responsive hydrogels for targeted cancer therapy.Gels2024;10:440 PMCID:PMC11275390

[17] Masaeli E,Rajabzadeh AR.Transforming cancer diagnosis and therapy through fluorescent hydrogels: a review.Adv Healthc Mater2026;15:e02577 PMCID:PMC12790332

[18] Sampath B.Theranostic magnetic hydrogels for treatment, recurrence prevention, tumour modelling and emerging applications in breast cancer management: a review.Int J Biol Macromol2026;359:151874

[19] Lee KK,Lee E.Multifunctional hydrogels for advanced cancer treatment: diagnostic imaging and therapeutic modalities.Gels2025;11:426 PMCID:PMC12191913

[20] Hoare TR.Hydrogels in drug delivery: progress and challenges.Polymer2008;49:1993-2007

[21] Peppas NA,Leobandung W.Hydrogels in pharmaceutical formulations.Eur J Pharm Biopharm2000;50:27-46

[22] Tibbitt MW.Hydrogels as extracellular matrix mimics for 3D cell culture.Biotechnol Bioeng2009;103:655-63 PMCID:PMC2997742

[23] Drury JL.Hydrogels for tissue engineering: scaffold design variables and applications.Biomaterials2003;24:4337-51

[24] Zhu H,Oh XY.Nanoarchitecture-integrated hydrogel systems toward therapeutic applications.ACS Nano2023;17:7953-78

[25] Lu P,Huang M.Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions.Signal Transduct Target Ther2024;9:166 PMCID:PMC11214942

[26] Guo L,Li H.Smart hydrogel: a new platform for cancer therapy.Adv Colloid Interface Sci2025;340:103470

[27] Lee KY.Alginate: properties and biomedical applications.Prog Polym Sci2012;37:106-26 PMCID:PMC3223967

[28] Augst AD,Mooney DJ.Alginate hydrogels as biomaterials.Macromol Biosci2006;6:623-33

[29] Rowley JA,Mooney DJ.Alginate hydrogels as synthetic extracellular matrix materials.Biomaterials1999;20:45-53

[30] Dash M,Ottenbrite R.Chitosan - a versatile semi-synthetic polymer in biomedical applications.Prog Polym Sci2011;36:981-1014

[31] Croisier F.Chitosan-based biomaterials for tissue engineering.Eur Polym J2013;49:780-92

[32] Sockett KA,Ungolan P,Grinstaff MW.Advancements in hyaluronic acid synthetic methodologies and their translational relevance.Chem Rev2026;126:3224-86

[33] Burdick JA.Hyaluronic acid hydrogels for biomedical applications.Adv Mater2011;23:H41-56 PMCID:PMC3730855

[34] Highley CB,Burdick JA.Recent advances in hyaluronic acid hydrogels for biomedical applications.Curr Opin Biotechnol2016;40:35-40

[35] Yue K,Alvarez MM,Annabi N.Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels.Biomaterials2015;73:254-71 PMCID:PMC4610009

[36] Caliari SR.A practical guide to hydrogels for cell culture.Nat Methods2016;13:405-14 PMCID:PMC5800304

[37] Gonzalez-Obeso C,Albert Scheel R.Delivering on the promise of recombinant silk-inspired proteins for drug delivery.Adv Drug Deliv Rev2023;192:114622 PMCID:PMC9812964

[38] Canal T.Correlation between mesh size and equilibrium degree of swelling of polymeric networks.J Biomed Mater Res1989;23:1183-93

[39] Zustiak SP.Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties.Biomacromolecules2010;11:1348-57 PMCID:PMC3050024

[40] Raeber GP,Hubbell JA.Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration.Biophys J2005;89:1374-88 PMCID:PMC1366622

[41] Rehmann MS,Kharkar PM.Tuning and predicting mesh size and protein release from step growth hydrogels.Biomacromolecules2017;18:3131-42 PMCID:PMC6699171

[42] Lutolf M,Zisch A,Hubbell J.Cell‐responsive synthetic hydrogels.Adv Mater2003;15:888-92

[43] Gill BJ,Roudsari LC.A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model.Cancer Res2012;72:6013-23 PMCID:PMC3632398

[44] Li JK,Wu XS.Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery.J Control Release1998;56:117-26

[45] Oh NG,Na YH.Fabrication of a PVA-based hydrogel microneedle patch.ACS Omega2022;7:25179-85 PMCID:PMC9330234

[46] Nguyen HX,Kim Y.Poly (vinyl alcohol) microneedles: fabrication, characterization, and application for transdermal drug delivery of doxorubicin.Eur J Pharm Biopharm2018;129:88-103

[47] Jain M,Thakur R.PVA/guanidinium oleate transdermal patch as a pH-responsive drug delivery system for the localized and targeted delivery of anticancer drugs.Mater Adv2024;5:1998-2011

[48] Tilghman RW,Mih JD.Matrix rigidity regulates cancer cell growth and cellular phenotype.PLoS One2010;5:e12905 PMCID:PMC2944843

[49] Gao Y,Ding B.A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel.J Drug Target2011;19:516-27

[50] Ma H,Cheng Y.PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.Biomaterials2014;35:8723-34

[51] Zhang, S.; Holmes, T.; Lockshin, C.; Rich, A.; New Collective Author. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane.Proc Natl Acad Sci U S A1993;90:3334-8 PMCID:PMC46294

[52] Hartgerink JD,Stupp SI.Self-assembly and mineralization of peptide-amphiphile nanofibers.Science2001;294:1684-8

[53] Um SH,Park N,Umbach CC.Enzyme-catalysed assembly of DNA hydrogel.Nat Mater2006;5:797-801

[54] Xing Y,Yang Y.Self-assembled DNA hydrogels with designable thermal and enzymatic responsiveness.Adv Mater2011;23:1117-21

[55] Rodell CB,Burdick JA.Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels.Biomacromolecules2013;14:4125-34 PMCID:PMC3851010

[56] Lin CC.PEG hydrogels for the controlled release of biomolecules in regenerative medicine.Pharm Res2009;26:631-43 PMCID:PMC5892412

[57] Censi R,Vermonden T.Hydrogels for protein delivery in tissue engineering.J Control Release2012;161:680-92

[58] Ding X.Weak bond-based injectable and stimuli responsive hydrogels for biomedical applications.J Mater Chem B2017;5:887-906 PMCID:PMC5650238

[59] Jalalvandi E.Shear thinning/self-healing hydrogel based on natural polymers with secondary photocrosslinking for biomedical applications.J Mech Behav Biomed Mater2019;90:191-201

[60] Shi Y,He C.Design of an injectable polypeptide hydrogel depot containing the immune checkpoint blocker anti-PD-L1 and doxorubicin to enhance antitumor combination therapy.Macromol Biosci2021;21:e2100049

[61] Siboro SAP,Ramesh K,Kim HR.Tunable porosity of covalently crosslinked alginate-based hydrogels and its significance in drug release behavior.Carbohydr Polym2021;260:117779

[62] Fairbanks BD,Bowman CN.Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility.Biomaterials2009;30:6702-7 PMCID:PMC2896013

[63] Shin GR,Ju HJ.Injectable click-crosslinked hydrogel containing resveratrol to improve the therapeutic effect in triple negative breast cancer.Mater Today Bio2022;16:100386 PMCID:PMC9386493

[64] Cao D,Akabar MD.Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.Artif Cells Nanomed Biotechnol2019;47:181-91

[65] Nguyen AK,Reipa V.Toxicity and photosensitizing assessment of gelatin methacryloyl-based hydrogels photoinitiated with lithium phenyl-2,4,6-trimethylbenzoylphosphinate in human primary renal proximal tubule epithelial cells.Biointerphases2019;14:021007 PMCID:PMC6499620

[66] Nguyen AK,Elespuru RK,Narayan RJ.The photoinitiator lithium phenyl (2,4,6-trimethylbenzoyl) phosphinate with exposure to 405 nm light is cytotoxic to mammalian cells but not mutagenic in bacterial reverse mutation assays.Polymers2020;12:1489 PMCID:PMC7408440

[67] Yesilyurt V,Appel EA,Langer R.Injectable self-healing glucose-responsive hydrogels with pH-regulated mechanical properties.Adv Mater2016;28:86-91 PMCID:PMC4825176

[68] Huang Z,Burch P,Cao Y.Injectable dynamic covalent hydrogels of boronic acid polymers cross-linked by bioactive plant-derived polyphenols.Biomater Sci2018;6:2487-95 PMCID:PMC6107875

[69] Deng CC,Abboud KA.Boronic acid-based hydrogels undergo self-healing at neutral and acidic pH.ACS Macro Lett2015;4:220-4

[70] Lee F,Kurisawa M.An injectable enzymatically crosslinked hyaluronic acid- hydrogel system with independent tuning of mechanical strength and gelation rate.Soft Matter2008;4:880-7

[71] Kurisawa M,Wang L.Injectable enzymatically crosslinked hydrogel system with independent tuning of mechanical strength and gelation rate for drug delivery and tissue engineering.J Mater Chem2010;20:5371

[72] Cheng E,Chen P.A pH-triggered, fast-responding DNA hydrogel.Angew Chem Int Ed Engl2009;48:7660-3

[73] Yang H,Kang H.Engineering target-responsive hydrogels based on aptamer-target interactions.J Am Chem Soc2008;130:6320-1 PMCID:PMC2757630

[74] Katopodi T,Floros G,Kosmidis C.Hybrid nanogel drug delivery systems: transforming the tumor microenvironment through tumor tissue editing.Cells2024;13:908 PMCID:PMC11171955

[75] Liu Y,Shi Q,Ma H.Tumor microenvironment-responsive polypeptide nanogels for controlled antitumor drug delivery.Front Pharmacol2021;12:748102 PMCID:PMC8578677

[76] Zhang H,Lee JY,Loh TP.Cancer biomarker-triggered disintegrable DNA nanogels for intelligent drug delivery.Nano Lett2020;20:8399-407

[77] Xu X,Lu C.Self-assembled ATP-responsive DNA nanohydrogel for specifically activated fluorescence imaging and chemotherapy in cancer cells.Anal Chem2022;94:10221-6

[78] Shang J,Li R,Wang Y.Bioorthogonal disassembly of hierarchical DNAzyme nanogel for high-performance intracellular microRNA imaging.Nano Lett2023;23:1386-94

[79] Su M,Chen J.Microfluidic synthesis of manganese-alginate nanogels with self-supplying H₂O₂ capability for synergistic chemo/chemodynamic therapy and boosting anticancer immunity.Chem Eng J2022;435:134926

[80] Sanati M.Liposome-integrated hydrogel hybrids: promising platforms for cancer therapy and tissue regeneration.J Control Release2024;368:703-27

[81] Binaymotlagh R,Chronopoulou L.Liposome-hydrogel composites for controlled drug delivery applications.Gels2024;10:284 PMCID:PMC11048854

[82] GuhaSarkar S,Sudhalkar N.Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot.Int J Nanomedicine2016;11:6435-48 PMCID:PMC5138055

[83] Mao Y,Chen G.Thermosensitive hydrogel system with paclitaxel liposomes used in localized drug delivery system for in situ treatment of tumor: better antitumor efficacy and lower toxicity.J Pharm Sci2016;105:194-204

[84] Bouché M,Sheikh S.Novel treatment for glioblastoma delivered by a radiation responsive and radiopaque hydrogel.ACS Biomater Sci Eng2021;7:3209-20 PMCID:PMC8411482

[85] Huang S,Zhao M.Nanocomposite hydrogels for biomedical applications.Bioeng Transl Med2022;7:e10315 PMCID:PMC9471997

[86] Wang C,Huang Y,Xu S.Coordination of injectable self-healing hydrogel with Mn-Zn ferrite@mesoporous silica nanospheres for tumor MR imaging and efficient synergistic magnetothermal-chemo-chemodynamic therapy.Chem Eng J2020;401:126100

[87] Yue J,Li L,Dong WF.Injectable carbon dots-based hydrogel for combined photothermal therapy and photodynamic therapy of cancer.ACS Appl Mater Interfaces2022;14:49582-91

[88] Vaziri A,Zhang P.Granular hydrogels as modular biomaterials: from structural design to biological responses.Adv Healthc Mater2026;15:e02462 PMCID:PMC12817117

[89] Daly AC,Segura T.Hydrogel microparticles for biomedical applications.Nat Rev Mater2020;5:20-43 PMCID:PMC8191408

[90] Sinclair A,Bai T,Jain P.Self-healing zwitterionic microgels as a versatile platform for malleable cell constructs and injectable therapies.Adv Mater2018;30:e1803087 PMCID:PMC6588167

[91] Zhong Z,Feng Z.Hydrogel local drug delivery systems for postsurgical management of tumors: Status Quo and perspectives.Mater Today Bio2024;29:101308 PMCID:PMC11550774

[92] Zhang J,Li A.Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection.Nat Nanotechnol2021;16:538-48

[93] Fu Z,Xue P.Implantable bioresponsive hydrogel prevents local recurrence of breast cancer by enhancing radiosensitivity.Front Bioeng Biotechnol2022;10:881544 PMCID:PMC9039615

[94] Yan X,Song Y.In situ thermal-responsive magnetic hydrogel for multidisciplinary therapy of hepatocellular carcinoma.Nano Lett2022;22:2251-60

[95] Zhou J,Chen H.pH-responsive nanocomposite hydrogel for simultaneous prevention of postoperative adhesion and tumor recurrence.Acta Biomater2023;158:228-38

[96] Amatya R,Park T.BSA/silver nanoparticle-loaded hydrogel film for local photothermal treatment of skin cancer.Pharm Res2021;38:873-83

[97] Seo JY,Kang TW.Electrostatically interactive injectable hydrogels for drug delivery.Tissue Eng Regen Med2018;15:513-20 PMCID:PMC6171702

[98] Akther F,Li Z,Ta HT.Hydrogels as artificial matrices for cell seeding in microfluidic devices.RSC Adv2020;10:43682-703 PMCID:PMC9058401

[99] Shin GR,Kim JH,Kim MS.Advances in injectable in situ-forming hydrogels for intratumoral treatment.Pharmaceutics2021;13:1953 PMCID:PMC8624884

[100] Han X,Wu Z,Qi X.Dynamic imine bond cross-linked self-healing thermosensitive hydrogels for sustained anticancer therapy via intratumoral injection.Mater Sci Eng C Mater Biol Appl2018;93:1064-72

[101] Wang Y,Hu W.In situ hydrogels prepared by photo-initiated crosslinking of acrylated polymers for local delivery of antitumor drugs.J Pharm Sci2023;112:1863-71

[102] Attama AA,Onokala OB,Onugwu AL.Nanogels as target drug delivery systems in cancer therapy: a review of the last decade.Front Pharmacol2022;13:874510 PMCID:PMC9493206

[103] Li X,Zhang C,Xing L.Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy.Bioact Mater2021;6:3473-84 PMCID:PMC8024537

[104] Qian K,Wan J.The studies about doxorubicin-loaded p(N-isopropyl-acrylamide-co-butyl methylacrylate) temperature-sensitive nanogel dispersions on the application in TACE therapies for rabbit VX2 liver tumor.J Control Release2015;212:41-9

[105] Ma X,Zhang R.Minimally invasive injection of biomimetic Nano@Microgel for in situ ovarian cancer treatment through enhanced photodynamic reactions and photothermal combined therapy.Mater Today Bio2023;20:100663 PMCID:PMC10232889

[106] Agrawal G.Functional microgels: recent advances in their biomedical applications.Small2018;14:e1801724

[107] Michela B.Liquid Biopsy: A family of possible diagnostic tools.Diagnostics2021;11:1391 PMCID:PMC8394215

[108] Raza A,Inchakalody VP.Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.J Exp Clin Cancer Res2022;41:99 PMCID:PMC8922757

[109] Kim YJ.Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects.Anal Bioanal Chem2024;416:2065-78

[110] Luchini A,Bishop B.Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.Nano Lett2008;8:350-61 PMCID:PMC2877922

[111] Tang J,Li Q.A DNA-based hydrogel for exosome separation and biomedical applications.Proc Natl Acad Sci U S A2023;120:e2303822120 PMCID:PMC10334772

[112] Chen B,Huang C.A light-induced hydrogel responsive platform to capture and selectively isolate single circulating tumor cells.Nanoscale2022;14:3504-12

[113] Kim YJ,Min J.Circulating tumor marker isolation with the chemically stable and instantly degradable (CSID) hydrogel immunospheres.Anal Chem2021;93:1100-9

[114] Kaniewska K,Karbarz M.Changes in the volume phase transition temperature of hydrogels for detection of the DNA hybridization process.Analyst2016;141:5815-21

[115] Xu Y,Luan C,Chen B.Hybrid hydrogel photonic barcodes for multiplex detection of tumor markers.Biosens Bioelectron2017;87:264-70

[116] Sun S.Recent advances in hydrogel-based biosensors for cancer detection.ACS Appl Mater Interfaces2024;16:46988-7002 PMCID:PMC11403555

[117] Lu H,Hasan E.Novabeads: stimuli-responsive signal-amplifying hydrogel microparticles for enzymeless fluorescence-based detection of microRNA biomarkers.Small2025;21:e2503990 PMCID:PMC12372440

[118] Ring A,Wicki A.Biology, vulnerabilities and clinical applications of circulating tumour cells.Nat Rev Cancer2023;23:95-111 PMCID:PMC9734934

[119] Capuozzo M,Santorsola M,Ottaiano A.Circulating tumor cells as predictive and prognostic biomarkers in solid tumors.Cells2023;12:2590 PMCID:PMC10670669

[120] Portella L,Guardascione G.CXCL12-loaded-hydrogel (CLG): a new device for metastatic circulating tumor cells (CTCs) capturing and characterization.Heliyon2024;10:e35524 PMCID:PMC11336720

[121] Sun W,Zhao X.Precise capture and dynamic release of circulating liver cancer cells with dual-histidine-based cell imprinted hydrogels.Adv Mater2024;36:e2402379

[122] Dawson SJ,Murtaza M.Analysis of circulating tumor DNA to monitor metastatic breast cancer.N Engl J Med2013;368:1199-209

[123] Garcia-Murillas I,Weigelt B.Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.Sci Transl Med2015;7:302ra133

[124] Zhao X,Zeng X,Chen J.Homogeneous extraction-free dual-ctDNA detection via DNA nanomaterial fusion for rapid breast cancer diagnosis.ACS Nano2025;19:42066-78

[125] Hou J,Yuan W.Thermosensitive hydrogel-enhanced RPA-CRISPR/Cas12a biosensor for ultrasensitive detection of methylated loci in breast cancer ctDNA.Anal Chim Acta2026;1388:345101

[126] McAlexander MA,Witwer KW.Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid.Front Genet2013;4:83 PMCID:PMC3655275

[127] Sourvinou IS,Lianidou ES.Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability.J Mol Diagn2013;15:827-34

[128] Jang W,Roh HK,Bong KW.Hydrogel-based in situ DNA extension assay for multiplexed and rapid detection of microRNA.Anal Chem2025;97:7317-24

[129] Chen D,Wei Y.Size-coded hydrogel microbeads for extraction-free serum multi-miRNAs quantifications with machine-learning-aided lung cancer subtypes classification.Nano Lett2025;25:453-60

[130] Lin Y,Wu Z.Microfluidic-enabled self-directed hydrogel microspheres for multiplexed microRNA assays.Anal Chem2025;97:1972-6

[131] Yao C,Lu X,Li Z.Hydrogel-based microdroplet ensembles encapsulating multiplexed EXPAR assays for trichromic digital profiling of microRNAs and in-depth classification of primary urethral cancers.Nano Lett2024;24:15861-9

[132] Yu W,Roberts D.Exosome-based liquid biopsies in cancer: opportunities and challenges.Ann Oncol2021;32:466-77 PMCID:PMC8268076

[133] Xu X,Zhang X.Decoding expression dynamics of protein and transcriptome at the single-cell level in paired picoliter chambers.Anal Chem2022;94:8164-73

[134] Miwa H,de Rutte J,Di Carlo D.Single-cell sorting based on secreted products for functionally defined cell therapies.Microsyst Nanoeng2022;8:84 PMCID:PMC9303846

[135] Yamagata C,Nakazato T.Oil-sealed RGD-modified alginate hydrogel microwell array for analysis of single-cell-derived extracellular vesicles and particles.Microsyst Nanoeng2025;11:238 PMCID:PMC12672703

[136] Lee SS,Sohn DK.Indocyanine green-loaded injectable alginate hydrogel as a marker for precision cancer surgery.Quant Imaging Med Surg2020;10:779-88 PMCID:PMC7136741

[137] Linders DGJ,Walker E.Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agent.Pharmacol Res2024;209:107464 PMCID:PMC12318534

[138] Yang HY,Sun XS.CD44-mediated tumor homing of hyaluronic acid nanogels for hypoxia-activated photodynamic therapy against tumor.Colloids Surf B Biointerfaces2023;228:113395

[139] Song P,Zuo X.DNA hydrogel with aptamer-toehold-based recognition, cloaking, and decloaking of circulating tumor cells for live cell analysis.Nano Lett2017;17:5193-8

[140] Chen T,Lin L.Mesoporous radiosensitized nanoprobe for enhanced NIR-II photoacoustic imaging-guided accurate radio-chemotherapy.Nano Res2022;15:4154-63

[141] Vahrmeijer AL,van der Vorst JR,Frangioni JV.Image-guided cancer surgery using near-infrared fluorescence.Nat Rev Clin Oncol2013;10:507-18 PMCID:PMC3755013

[142] Saxena V,Shao J.Degradation kinetics of indocyanine green in aqueous solution.J Pharm Sci2003;92:2090-7

[143] Andreiuk B,Bernhardt E.Fighting aggregation-caused quenching and leakage of dyes in fluorescent polymer nanoparticles: universal role of counterion.Chem Asian J2019;14:836-46

[144] Liu C,Shi R,Ji S.A near infrared-modulated thermosensitive hydrogel for stabilization of indocyanine green and combinatorial anticancer phototherapy.Biomater Sci2019;7:1705-15

[145] Donnelly RF,Garland MJ.Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery.Adv Funct Mater2012;22:4879-90 PMCID:PMC3627464

[146] Park J,Kim E.CD44-specific supramolecular hydrogels for fluorescence molecular imaging of stem-like gastric cancer cells.Integr Biol2013;5:669-72

[147] Yang J,Teng X.Tumor microenvironment-responsive hydrogel for direct extracellular ATP imaging-guided surgical resection with clear boundaries.Adv Healthc Mater2023;12:e2301084

[148] Walker E,Abenojar E.Formulation of a thermosensitive imaging hydrogel for topical application and rapid visualization of tumor margins in the surgical cavity.Cancers2022;14:3459 PMCID:PMC9323389

[149] Guo P,Shang W.Targeting tumour surface collage with hydrogel probe: a new strategy to enhance intraoperative imaging sensitivity and stability of bladder cancer.Eur J Nucl Med Mol Imaging2024;51:4165-76

[150] Lee SS.Near-infrared dye-loaded thermosensitive hydrogels as novel fluorescence tissue markers.Gels2025;11:649 PMCID:PMC12385789

[151] Upputuri PK.Photoacoustic imaging in the second near-infrared window: a review.J Biomed Opt2019;24:1-20 PMCID:PMC6990072

[152] Sun X,Liu X,Shi Y.Tumor-specific enhanced NIR-II photoacoustic imaging via photothermal and low-pH coactivated AuNR@PNIPAM-VAA nanogel.J Nanobiotechnology2024;22:326 PMCID:PMC11163807

[153] Jo J,Gonzalez ME.Personalized oncology by in vivo chemical imaging: photoacoustic mapping of tumor oxygen predicts radiotherapy efficacy.ACS Nano2023;17:4396-403 PMCID:PMC10149113

[154] Folz J,Eido A.Photoacoustic chemical imaging of tumor microenvironment pH for prediction of chemotherapeutic efficacy in breast cancer.Nano Lett2025;25:14808-16 PMCID:PMC12836281

[155] Tyler B,Li KW.A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats.J Neurosurg2010;113:210-7

[156] Wang C,Zhang X.In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy.Sci Transl Med2018;10:eaan3682

[157] Chen Q,Zhang X.In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment.Nat Nanotechnol2019;14:89-97

[158] Liu Y,Lu S.Injectable hydrogel platform with biodegradable Dawson-type polyoxometalate and R848 for combinational photothermal-immunotherapy of cancer.Biomater Sci2022;10:1257-66

[159] Zhao J,Zhu C.Design of phase-changeable and injectable alginate hydrogel for imaging-guided tumor hyperthermia and chemotherapy.ACS Appl Mater Interfaces2018;10:3392-404

[160] Shi J,Wooster R.Cancer nanomedicine: progress, challenges and opportunities.Nat Rev Cancer2017;17:20-37 PMCID:PMC5575742

[161] Guo Y,Wu Y.Injectable pH-responsive polypeptide hydrogels for local delivery of doxorubicin.Nanoscale Adv2024;6:6420-32 PMCID:PMC11533052

[162] Shi Y,Xu S.Injectable doxorubicin-loaded hyaluronic acid-based hydrogel for locoregional therapy and inhibiting metastasis of breast cancer.Colloids Surf B Biointerfaces2025;247:114433

[163] Zhang Q,Chen H.Injectable hydrogel with doxorubicin-loaded ZIF-8 nanoparticles for tumor postoperative treatments and wound repair.Sci Rep2024;14:9983 PMCID:PMC11063161

[164] Mohite P,Munde S.Hydrogel-forming microneedles in the management of dermal disorders through a non-invasive process: a review.Gels2024;10:719 PMCID:PMC11594199

[165] Zhu L,Gao H,Zhang L.Enhancing melanoma therapy with hydrogel microneedles.Front Oncol2025;15:1590534 PMCID:PMC12043666

[166] Wang C,Hochu GM,Gu Z.Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody.Nano Lett2016;16:2334-40

[167] Zhang Z,Zeng W,Zhu C.A hyaluronic acid-based dual-functional hydrogel microneedle system for sequential melanoma ablation and skin regeneration.Int J Biol Macromol2024;283:138039

[168] Messing EM,Lerner SP.Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial.JAMA2018;319:1880-8 PMCID:PMC6583489

[169] Zheng B,Wang J.A mucoadhesive-to-penetrating nanomotors-in-hydrogel system for urothelium-oriented intravesical drug delivery.J Nanobiotechnology2024;22:560 PMCID:PMC11401290

[170] Sahin U,Miller M.Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.Nature2017;547:222-6

[171] Ott PA,Keskin DB.An immunogenic personal neoantigen vaccine for patients with melanoma.Nature2017;547:217-21 PMCID:PMC5577644

[172] Gong N,El-Mayta R,Weissman D.Enhancing in situ cancer vaccines using delivery technologies.Nat Rev Drug Discov2024;23:607-25

[173] Sakuishi K,Sullivan JM,Kuchroo VK.Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.J Exp Med2010;207:2187-94 PMCID:PMC2947065

[174] Fan S,Yan Z,He B.Lipid-based nanoparticles for cancer immunotherapy.Med Rev2023;3:230-69 PMCID:PMC10542882

[175] Mikhail AS,Mauda-Havakuk M,Arrichiello A.Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer.Adv Drug Deliv Rev2023;202:115083 PMCID:PMC11616795

[176] Pechnikova NA,Latypova AA.Implantable biomaterials for cancer immunotherapies.Adv Funct Mater2025;35:2416813

[177] Jia W,Xie Y,Chen Y.Advanced polymeric nanoparticles for cancer immunotherapy: materials engineering, immunotherapeutic mechanism and clinical translation.Adv Mater2025;37:e2413603

[178] Qiu W,Shen F.Rapid hemostasis tumor in situ hydrogel vaccines for colorectal cancer chemo-immunotherapy.ACS Appl Mater Interfaces2024;16:61679-91

[179] Ji P,Zhang S.Modular hydrogel vaccine for programmable and coordinate elicitation of cancer immunotherapy.Adv Sci2023;10:e2301789 PMCID:PMC10401092

[180] Zhao X,Li Z.A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma.NPJ Vaccines2025;10:1 PMCID:PMC11699128

[181] Wang ZL,Sun YQ.An injectable oncolytic hydrogel platform for in situ dendritic cell vaccination to boost antitumor immunity.Biomater Sci2025;13:3016-29

[182] Kenny HA,Yamada SD.Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.Int J Cancer2007;121:1463-72

[183] Fischbach C,Matsumoto T.Engineering tumors with 3D scaffolds.Nat Methods2007;4:855-60

[184] Gao H,Ferretti S.High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.Nat Med2015;21:1318-25

[185] Tian YF,Schneider RS.Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells.Biomaterials2015;73:110-9 PMCID:PMC4623826

[186] Duan Y,Jia Y.Fully synthetic nanofibrillar hydrogel for the growth and enzyme-free release of patient-derived ovarian tumor organoids.Biomaterials2026;326:123723

[187] Gjorevski N,Manfrin A.Designer matrices for intestinal stem cell and organoid culture.Nature2016;539:560-4

[188] Ng S,Pek MMX,Kurisawa M.Mechanically and chemically defined hydrogel matrices for patient-derived colorectal tumor organoid culture.Biomaterials2019;219:119400

[189] Cruz-Acuña R,Sugiura K.Engineered hydrogel reveals contribution of matrix mechanics to esophageal adenocarcinoma and identifies matrix-activated therapeutic targets.J Clin Invest2023;133:e168146 PMCID:PMC10688988

[190] Mosquera MJ,Bareja R.Extracellular matrix in synthetic hydrogel-based prostate cancer organoids regulate therapeutic response to EZH2 and DRD2 Inhibitors.Adv Mater2022;34:e2100096 PMCID:PMC8820841

[191] Rice AJ,Lachowski D.Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells.Oncogenesis2017;6:e352 PMCID:PMC5541706

[192] Tao T,Gan Z.A synthetic hydrogel with tunable stiffness for engineering pancreatic cancer organoids and drug testing.ACS Biomater Sci Eng2025;11:5000-11

[193] Cavo M,Pulsoni I,Fato M.A new cell-laden 3D Alginate-Matrigel hydrogel resembles human breast cancer cell malignant morphology, spread and invasion capability observed “in vivo”.Sci Rep2018;8:5333 PMCID:PMC5871779

[194] Jung YH,Park K.Drug screening by uniform patient derived colorectal cancer hydro-organoids.Biomaterials2021;276:121004

[195] Prince E,Ba-Alawi W.Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.Nat Commun2022;13:1466 PMCID:PMC8933543

[196] LeSavage BL,Huerta-López C.Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids.Nat Mater2024;23:1138-49 PMCID:PMC13098013

[197] Luo X,Zhu C.Hydrogel-based colorectal cancer organoid co-culture models.Acta Biomater2021;132:461-72

[198] Zhao Y,Liu H,Tan WS.A chemically defined, mechanically tunable, and bioactive hyaluronic acid/alginate double-network hydrogel for liver cancer organoid construction.Int J Biol Macromol2024;282:136707

[199] Jung M,Skhinas JN.High-throughput 3D engineered paediatric tumour models for precision medicine.Mol Syst Biol2025;21:1748-77 PMCID:PMC12673126

[200] Miebach L,Hübner L.Protocol for generating a 3D hydrogel-based tumor resection model in vitro using pancreatic cancer cells.STAR Protoc2026;7:104416 PMCID:PMC12969724

[201] Zhang S,Zhang Z,Jin Z.Advancements in hydrogel-based embolic agents: categorized by therapeutic mechanisms.Cancer Med2024;13:e70183 PMCID:PMC11497111

[202] Lee SY,Hwang C.Intravascular casting radiopaque hydrogel systems for transarterial chemo/cascade catalytic/embolization therapy of hepatocellular carcinoma.Small2024;20:e2400287

[203] Xu H,Yakovliev A.Nanoliposomes co-encapsulating CT imaging contrast agent and photosensitizer for enhanced, imaging guided photodynamic therapy of cancer.Theranostics2019;9:1323-35 PMCID:PMC6401496

[204] Lee SM,Kim T.Radiopaque hydrogel-in-liposomes towards theranostic applications for malignant tumors.Biomed Pharmacother2025;183:117822

[205] Wang B,Teng Y.Current advance of nanotechnology in diagnosis and treatment for malignant tumors.Signal Transduct Target Ther2024;9:200 PMCID:PMC11323968

[206] Hamad HT.Benzothiazole derivatives in cancer treatment: synthesis and therapeutic potential: review.MedMat2025;2:17-32

[207] Lee KK,Lee SC.MnCO₃-mineralized polydopamine nanoparticles as an activatable theranostic agent for dual-modality imaging-guided photothermal therapy of cancers.Theranostics2022;12:6762-78 PMCID:PMC9516237

[208] Ryu JH,Sun IC.Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy.Adv Drug Deliv Rev2012;64:1447-58

[209] Dessale M,Mengist HM.Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis.Int J Nanomedicine2022;17:3735-49 PMCID:PMC9427008

[210] Annigeri NC,Vijayakumar DB.Theragnosis using fluorescence: a review.J Adv Dental Pract Res2024;2:59-61

[211] Jirvankar P,Chambhare N.Harnessing biopolymer gels for theranostic applications: imaging agent integration and real-time monitoring of drug delivery.Gels2024;10:535 PMCID:PMC11353668

[212] Gao Z,Liu Q.Mechanism and design of organic afterglow luminescent probes for cancer theranostics.MedMat2024;1:27-39

[213] Wang S,Mei Z.Metalloptosis: metal ions-induced programmed cell death based on nanomaterials for cancer therapy.MedMat2024;1:6-26

[214] Mantooth SM,Green WD.An injectable hydrogel enhances intratumoral retention and antitumor efficacy of cytokine immunotherapy in murine triple negative breast tumor models.J Control Release2025;383:113761 PMCID:PMC13335766

[215] Vu TT,Kim SH,Park SH.Injectable and multifunctional hydrogels based on poly(N-acryloyl glycinamide) and alginate derivatives for antitumor drug delivery.ACS Appl Mater Interfaces2024;16:15322-35

[216] Liang S,Ding J,He C.Injectable matrix metalloproteinase-responsive polypeptide hydrogels as drug depots for antitumor chemo-immunotherapy.Pharmaceutics2025;17:1453 PMCID:PMC12655423

[217] Gierlich P,Behan K,Senge MO.Antitumor immunity mediated by photodynamic therapy using injectable chitosan hydrogels for intratumoral and sustained drug delivery.Biomacromolecules2024;25:24-42 PMCID:PMC10778090

[218] Wang Y,Meng Z.In situ biosynthesis of photothermal parasite for fluorescence imaging-guided photothermal therapy of tumors.Gels2022;8:754 PMCID:PMC9689737

[219] Xu Y,Liu W.Aggregation-induced-emission luminogens functionalized MXene nanosheets for stimuli-responsive hydrogel in pyroptosis-mediated choroidal melanoma therapy.Nanomicro Lett2026;18:282 PMCID:PMC12988077

[220] Heng C,Hui J,Fan D.Neodymium and manganese ions co-doped whitlockite for temperature monitoring, photothermal therapy, and bone tissue repair in osteosarcoma.J Colloid Interface Sci2024;653:1488-503

[221] Lee WT,Kim SS.Combined antitumor therapy using in situ injectable hydrogels formulated with albumin nanoparticles containing indocyanine green, chlorin e6, and perfluorocarbon in hypoxic tumors.Pharmaceutics2022;14:148 PMCID:PMC8781012

[222] Peng Z,Wang Y.Self-assembling imageable silk hydrogels for the focal treatment of osteosarcoma.Front Cell Dev Biol2022;10:698282 PMCID:PMC9251127

[223] Liu M,Zhou Y.A novel coacervate embolic agent for tumor chemoembolization.Adv Healthc Mater2024;13:e2304488

[224] Peng Y,Liang X.Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity.J Control Release2025;380:1-16

[225] Dong YC,Hsu JC.Novel combination treatment for melanoma: FLASH radiotherapy and immunotherapy delivered by a radiopaque and radiation responsive hydrogel.Chem Mater2023;35:9542-51 PMCID:PMC11198981

[226] Delgado JF,Varble N.X-ray imageable, drug-loaded hydrogel that forms at body temperature for image-guided, needle-based locoregional drug delivery.Sci Rep2024;14:13352 PMCID:PMC11164888

[227] Som A,Wehrenberg-Klee E.Percutaneous intratumoral immunoadjuvant Gel increases the abscopal effect of cryoablation for checkpoint inhibitor resistant cancer.Adv Healthc Mater2024;13:e2301848 PMCID:PMC10922912

[228] Ranjbar-Navazi Z,Abdolahinia ED,Davaran S.MUC-1 aptamer conjugated InP/ZnS quantum dots/nanohydrogel fluorescent composite for mitochondria-mediated apoptosis in MCF-7 cells.Mater Sci Eng C Mater Biol Appl2021;118:111469

[229] Wang Y,Chen M.Application of near-infrared-activated and ATP-responsive trifunctional upconversion nano-jelly for in vivo tumor imaging and synergistic therapy.Biosens Bioelectron2024;250:116094

[230] Shuhendler AJ,Oakden W.Thermally-triggered ‘off-on-off’ response of gadolinium-hydrogel-lipid hybrid nanoparticles defines a customizable temperature window for non-invasive magnetic resonance imaging thermometry.J Control Release2012;157:478-84

[231] Zhou Y,Luo Y.Achieving complete tumor clearance: a minimalist manganese hydrogel for magnetic resonance imaging-guided synergetic microwave ablation and chemodynamic therapy.Adv Healthc Mater2024;13:e2303268

[232] Shazeeb MS,Konowicz PA.Assessment of in vivo degradation profiles of hyaluronic acid hydrogels using temporal evolution of chemical exchange saturation transfer (CEST) MRI.Biomaterials2018;178:326-38

[233] Dorsey SM,Singh A.Visualization of injectable hydrogels using chemical exchange saturation transfer MRI.ACS Biomater Sci Eng2015;1:227-37

[234] Zhu W,Kuddannaya S.In vivo imaging of composite hydrogel scaffold degradation using CEST MRI and two-color NIR imaging.Adv Funct Mater2019;29:1903753 PMCID:PMC7079757

[235] Park SW,Han X.Preclinical application of CEST MRI to detect early and regional tumor response to local brain tumor treatment.Pharmaceutics2024;16:101 PMCID:PMC10820766

[236] Lusic H.X-ray-computed tomography contrast agents.Chem Rev2013;113:1641-66 PMCID:PMC3878741

[237] Li X,Li B.Recent progress in advanced hydrogel-based embolic agents: from rational design strategies to improved endovascular embolization.Adv Healthc Mater2023;12:e2202787

[238] Isaac EI,Dault JB,McGhee A.Transarterial chemoembolization with LC bead LUMI followed by stereotactic body radiation therapy in treatment of hepatocellular carcinoma.Adv Radiat Oncol2022;7:100830 PMCID:PMC8767242

[239] Mikhail AS,Negussie AH.Cone-beam computed tomography-based spatial prediction of drug dose after transarterial chemoembolization using radiopaque drug-eluting beads in woodchuck hepatocellular carcinoma.Invest Radiol2022;57:495-501 PMCID:PMC11493181

[240] Bakos O,Rouleau S.Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity.J Immunother Cancer2018;6:86 PMCID:PMC6122574

[241] Pantel K.Minimal residual disease as a target for liquid biopsy in patients with solid tumours.Nat Rev Clin Oncol2025;22:65-77

[242] Løberg M,Bretthauer M.Benefits and harms of mammography screening.Breast Cancer Res2015;17:63 PMCID:PMC4415291

[243] Schiffman JD,Gibbs P.Early detection of cancer: past, present, and future.Am Soc Clin Oncol Educ Book2015;57-65

[244] Feng Z,Lu Y.Circulating tumor cells in the early detection of human cancers.Int J Biol Sci2022;18:3251-65 PMCID:PMC9134923

[245] Crosby D,Brindle KM.Early detection of cancer.Science2022;375:eaay9040

[246] Zhang Y,Tian Y.Gold nanorods-mediated efficient synergistic immunotherapy for detection and inhibition of postoperative tumor recurrence.Acta Pharm Sin B2021;11:1978-92 PMCID:PMC8343192

[247] Sun L,Tian L.ATP-responsive smart hydrogel releasing immune adjuvant synchronized with repeated chemotherapy or radiotherapy to boost antitumor immunity.Adv Mater2021;33:e2007910

[248] Zhao H,Zheng C.Implantable bioresponsive nanoarray enhances postsurgical immunotherapy by activating pyroptosis and remodeling tumor microenvironment.Adv Funct Mater2020;30:2005747

[249] Wang D,Duan J.Enrichment and sensing tumor cells by embedded immunomodulatory DNA hydrogel to inhibit postoperative tumor recurrence.Nat Commun2023;14:4511 PMCID:PMC10374534

[250] Geng S,Wang J.Ultrasensitive optical detection and elimination of residual microtumors with a postoperative implantable hydrogel sensor for preventing cancer recurrence.Adv Mater2024;36:e2307923

[251] Li X,Wang F.Theranostic hydrogels: construction strategies and applications.Chem Eng J2025;505:159545

[252] Maitz MF,Tsurkan MV,Beyrich T.Bio-responsive polymer hydrogels homeostatically regulate blood coagulation.Nat Commun2013;4:2168 PMCID:PMC3759053

[253] Jiang Y,Niu S.Wireless, closed-loop, smart bandage with integrated sensors and stimulators for advanced wound care and accelerated healing.Nat Biotechnol2023;41:652-62

[254] Mostafalu P,Rahimi R.Smart bandage for monitoring and treatment of chronic wounds.Small2018;14:e1703509

[255] Xu G,Cheng C.Battery‐free and wireless smart wound dressing for wound infection monitoring and electrically controlled on‐demand drug delivery.Adv Funct Mater2021;31:2100852

[256] Ge Z,Tao Y.Wireless and closed-loop smart dressing for exudate management and on-demand treatment of chronic wounds.Adv Mater2023;35:e2304005

[257] Yang C,Hou W.Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.Sci Adv2022;8:eadd3197 PMCID:PMC9710866

[258] Zheng X,Ju M,Huang H.A chemical biology toolbox to overcome the hypoxic tumor microenvironment for photodynamic therapy: a review.Biomater Sci2022;10:4681-93

[259] Corbet C.Tumour acidosis: from the passenger to the driver’s seat.Nat Rev Cancer2017;17:577-93

[260] Gorrini C,Mak TW.Modulation of oxidative stress as an anticancer strategy.Nat Rev Drug Discov2013;12:931-47

[261] Singleton DC,Wilson WR.Therapeutic targeting of the hypoxic tumour microenvironment.Nat Rev Clin Oncol2021;18:751-72

[262] Zhao F,Gao H.Cuproptosis: an emerging domain for copper-based nanomaterials mediated cancer therapy.MedMat2024;1:74-94

[263] Chen J,Swarbrick A.Spatial landscapes of cancers: insights and opportunities.Nat Rev Clin Oncol2024;21:660-74

[264] Beeghly GF,Riter RN.Measuring and modelling tumour heterogeneity across scales.Nat Rev Bioeng2023;1:712-30

[265] Brindle K.New approaches for imaging tumour responses to treatment.Nat Rev Cancer2008;8:94-107

[266] Abramson A,Khan Y.A flexible electronic strain sensor for the real-time monitoring of tumor regression.Sci Adv2022;8:eabn6550 PMCID:PMC9481124

[267] Shah BA,Li Y.Shining light on immunotherapy in metastatic urothelial carcinoma: trends and prospects.MedMat2025;2:240-52

[268] Lin CC.Hydrogels in controlled release formulations: network design and mathematical modeling.Adv Drug Deliv Rev2006;58:1379-408

[269] Murdan S.Electro-responsive drug delivery from hydrogels.J Control Release2003;92:1-17

[270] Yuk H,Zhao X.Hydrogel bioelectronics.Chem Soc Rev2019;48:1642-67

[271] Kim HJ,Lee S,Kim D.Materials design and integration strategies for soft bioelectronics in digital healthcare.Nat Rev Mater2025;10:654-73

[272] Subba SH.In situ cancer-cell-triggered visible changes in mechanical properties, electroconductivity, and adhesiveness of a MnO₂@PD-based mineralized hydrogel.ACS Appl Mater Interfaces2023;15:38357-66

[273] Qu J,Chen S.Multifunctional hydrogel electronics for closed-loop antiepileptic treatment.Sci Adv2024;10:eadq9207 PMCID:PMC11584000

[274] Yoo H,Kim J.Ionic diode-based drug delivery system.Adv Mater2025;37:e2412377

[275] Cui H,Li Z.Dynamic bonds enabled hydrogel adhesives: advancing ophthalmic repair and regeneration.MedMat2025;2:188-94

[276] Wang J,Lu H.Engineering programmable nanobiomaterials (PNBMs) for cancer nanotherapy.MedMat2025;2:1-16

[277] Mndlovu H,du Toit LC.A review of biomaterial degradation assessment approaches employed in the biomedical field.npj Mater Degrad2024;8:66

[278] Longmire M,Kobayashi H.Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.Nanomedicine2008;3:703-17 PMCID:PMC3407669

[279] Tsoi KM,Ma XZ.Mechanism of hard-nanomaterial clearance by the liver.Nat Mater2016;15:1212-21 PMCID:PMC5132626

[280] Dong YC,Uman S,Cormode DP.Detecting and monitoring hydrogels with medical imaging.ACS Biomater Sci Eng2021;7:4027-47 PMCID:PMC8440385

[281] Mariani E,Borzì RM.Biomaterials: foreign bodies or tuners for the immune response?.Int J Mol Sci2019;20:636 PMCID:PMC6386828

[282] Butenko S,Guerrero-Juarez CF.Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing.Nat Commun2024;15:6820 PMCID:PMC11315930

[283] Gavish Moscovitz, A.; Simaan Yameen, H.; Bar-Am, O.; Seliktar, D. Evaluating cross-linking efficiency and cytocompatibility of three commonly used photoinitiators across different cell-compatible hydrogel platforms.Biomacromolecules2025;26:6817-33 PMCID:PMC12522141

[284] U.S. Food and Drug Administration. 510(k) premarket notification: MARKIT Tissue Marker (K121964). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K121964. (accessed 2026-09-16)

[285] U.S. Food and Drug Administration. 510(k) premarket notification: HydroMARK Breast Biopsy Site Marker (K212158). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?id=K212158. (accessed 2026-09-16)

[286] Mandal A,Anselmo AC.Hydrogels in the clinic.Bioeng Transl Med2020;5:e10158 PMCID:PMC7237140

[287] Saputri RI,Rodgers AM.Hydrogel-based devices for cancer diagnostics: a systematic review of materials and biomarkers.Future Sci OA2025;11:2587305 PMCID:PMC12645877

[288] U.S. Food and Drug Administration. Orphan drug designations and approvals: JELMYTO (Mitomycin). https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=445114. (accessed 2026-09-16)

[289] U.S. Food and Drug Administration. FDA approves mitomycin intravesical solution for recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer. 2025. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-mitomycin-intravesical-solution-recurrent-low-grade-intermediate-risk-non-muscle. (accessed 2026-09-16)

[290] U.S. Food and Drug Administration. Premarket approval: Embrace Hydrogel Embolic System (P250003). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P250003. (accessed 2026-09-16)

[291] U.S. Food and Drug Administration. Device classification under section 513(f)(2) (de novo): SpaceOAR System (DEN140030). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN140030. (accessed 2026-09-16)

[292] U.S. Food and Drug Administration. 510(k) premarket notification: Barrigel Injectable Gel (K220641). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?id=K220641. (accessed 2026-09-16)

[293] Clegg JR,Zhao Z.Hydrogels in the clinic: an update.Bioeng Transl Med2024;9:e10680 PMCID:PMC11558196

[294] Abi-Jaoudeh N,Dey C.Multicenter randomized trial evaluating the safety and effectiveness of the instylla hydrogel embolic system for vascular occlusion of hypervascular tumors.J Vasc Interv Radiol2026;37:108946

[295] Wang F,Liu J.Cancer theranostic platforms based on injectable polymer hydrogels.Biomater Sci2021;9:3543-75

[296] Wu H,Chen Q.Hydrogels: current biomedical applications and future directions.Mol Biomed2026;7:123 PMCID:PMC13433736

[297] Carballo-Pedrares N,Alonso MJ.Clinical translation of injectable hydrogels: from bioactive polymers to long-acting drug delivery systems.Drug Deliv Transl Res2026;16:1685-708 PMCID:PMC13183726

[298] U.S. Food and Drug Administration. Frequently asked questions about combination products. https://www.fda.gov/combination-products/about-combination-products/frequently-asked-questions-about-combination-products. (accessed 2026-09-16)

[299] National Cancer Institute. Immune checkpoint inhibitors. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors. (accessed 2026-09-16)

[300] Viola M,Seiça R.Subcutaneous delivery of monoclonal antibodies: how do we get there?.J Control Release2018;286:301-14

[301] U.S. Food and Drug Administration. Approved cellular and gene therapy products. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products. (accessed 2026-09-16)

[302] National Cancer Institute. CAR T cells: engineering patients’ immune cells to treat their cancers. https://www.cancer.gov/about-cancer/treatment/research/car-t-cells. (accessed 2026-09-16)

[303] Kelley B.Industrialization of mAb production technology: the bioprocessing industry at a crossroads.MAbs2009;1:443-52 PMCID:PMC2759494

[304] Gao Y.Quantifying the trade-off between stiffness and permeability in hydrogels.Soft Matter2022;18:7735-40

[305] Chavda H.Effect of crosslinker concentration on characteristics of superporous hydrogel.Int J Pharm Investig2011;1:17-21 PMCID:PMC3465110

[306] Lee S,Yang F.The effects of varying poly(ethylene glycol) hydrogel crosslinking density and the crosslinking mechanism on protein accumulation in three-dimensional hydrogels.Acta Biomater2014;10:4167-74

[307] Lee S,Yang F.Effects of the poly(ethylene glycol) hydrogel crosslinking mechanism on protein release.Biomater Sci2016;4:405-11 PMCID:PMC5127629

[308] Alix-Panabières C.Liquid biopsy: from discovery to clinical application.Cancer Discov2021;11:858-73

[309] Liu L,Zhou W.An artificial antibody for exosome capture by dull template imprinting technology.J Mater Chem B2022;10:6655-63

[310] Liu L,Li X.Antibody-free hydrogel with the synergistic effect of cell imprinting and boronate affinity: toward the selective capture and release of undamaged circulating tumor cells.Small2020;16:e1904199

[311] Zuo H,Chen J,Li Y.Recent advances in smart stimulus-responsive hydrogels for precision drug delivery in tumours.Gels2026;12:98 PMCID:PMC12941131

[312] Ding H,Fu S.Preparation and application of pH-responsive drug delivery systems.J Control Release2022;348:206-38

[313] Xue W,Yi K,Ren H.Hepatocellular carcinoma biomarkers screening based on hydrogel photonic barcodes with tyramine deposition amplified ELISA.Biosens Bioelectron2024;255:116270

[314] Zorrón M,Sharma R.Emerging 2D nanomaterials-integrated hydrogels: advancements in designing theragenerative materials for bone regeneration and disease therapy.Adv Sci2024;11:e2403204 PMCID:PMC11336986

[315] Shen C,Xiao X.Hydrogels for in vivo biomedical applications: recent advances and future perspectives.J Mater Chem B2026;14:2386-406

[316] Rodriguez-Rivera GJ,Shah V,Cosgriff-Hernandez E.A user’s guide to degradation testing of polyethylene glycol-based hydrogels: from in vitro to in vivo studies.J Biomed Mater Res A2024;112:1200-12 PMCID:PMC11600467

[317] Schneider EL,Reid R,Santi DV.Hydrogel drug delivery system using self-cleaving covalent linkers for once-a-week administration of exenatide.Bioconjug Chem2016;27:1210-5

[318] Herrmann A,Schedler U.Hydrogels and their role in biosensing applications.Adv Healthc Mater2021;10:e2100062 PMCID:PMC11468738

[319] Han X,To AKW.CEST MRI detectable liposomal hydrogels for multiparametric monitoring in the brain at 3T.Theranostics2020;10:2215-28 PMCID:PMC7019148

[320] Guan Y,Hou S.Fluorescent self-reporting theranostic platforms for tumour therapy: from cytotoxin release monitoring to therapeutic feedback evaluation.J Mater Chem B2026;14:5836-58

[321] Garcia-Garcia A,Lanceros-Mendez S,Alvarez LP.Biodegradable natural hydrogels for tissue engineering, controlled release, and soil remediation.Polymers2024;16:2599 PMCID:PMC11435712

[322] Dagogo-Jack I.Tumour heterogeneity and resistance to cancer therapies.Nat Rev Clin Oncol2018;15:81-94

[323] Sobczak M.Enzyme-responsive hydrogels as potential drug delivery systems-state of knowledge and future prospects.Int J Mol Sci2022;23:4421 PMCID:PMC9031066

[324] Zhang Y,Wei C.Diselenide-containing poly(ε-caprolactone)-based thermo-responsive hydrogels with oxidation and reduction-triggered degradation.Mater Today Chem2017;4:172-9

[325] Huang W,Zhao Y.Janus-inspired core-shell structure hydrogel programmatically releases melatonin for reconstruction of postoperative bone tumor.ACS Appl Mater Interfaces2023;15:2639-55 PMCID:PMC9869893

[326] Komatsu H,Tamaru S,Ikeda M.Supramolecular hydrogel exhibiting four basic logic gate functions to fine-tune substance release.J Am Chem Soc2009;131:5580-5

[327] Badeau BA,Arakawa CK,DeForest CA.Engineered modular biomaterial logic gates for environmentally triggered therapeutic delivery.Nat Chem2018;10:251-8 PMCID:PMC5822735

[328] Liu GF,Feng CL.Installing logic gates to multiresponsive supramolecular hydrogel co-assembled from phenylalanine amphiphile and bis(pyridinyl) derivative.Langmuir2015;31:7122-8

[329] Webber MJ.Dynamic and reconfigurable materials from reversible network interactions.Nat Rev Mater2022;7:541-56

[330] Picchioni F.Hydrogels based on dynamic covalent and non covalent bonds: a chemistry perspective.Gels2018;4:21 PMCID:PMC6318606

[331] Cao LQ,Liu Y,Zeng L.Application of cancer organoids: the forefront of personalized oncology and preclinical testing.Organoid Res2025;1:025050008

[332] Wensink GE,Mullenders J.Patient-derived organoids as a predictive biomarker for treatment response in cancer patients.NPJ Precis Oncol2021;5:30 PMCID:PMC8042051